Horizon scanning: Lenalidomide on fast-track review by the USFDA for mantle cell lymphoma
Source: Reuters Health News
Area: News
According to a report by Reuters Health News, the US Food and Drug Administration (FDA) has granted priority review for lenalidomide used for the treatment of relapsed or refractory mantle cell lymphoma
Source: NeLM - News - Category: Drugs & Pharmacology Source Type: news
More News: Drugs & Pharmacology | Food and Drug Administration (FDA) | Health | Lymphoma | PET Scan | Revlimid